Weldesenbet Adisu Birhanu, Kebede Sewnet Adem, Tusa Biruk Shalmeno
Department of Epidemiology and Biostatistics, College of Health and Medical Sciences, Haramaya University, Haramaya, Ethiopia.
Department of Epidemiology and Biostatistics, Institute of Public Health, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia.
Depress Res Treat. 2020 Dec 9;2020:6633686. doi: 10.1155/2020/6633686. eCollection 2020.
Low- and middle-income countries of which Ethiopia is one bears the high burden of depression among human immune deficiency virus and acquired immune deficiency syndrome (HIV/AIDS) patients. Several factors have been identified as being associated with increased depression among HIV/AIDS patients including poor social support. However, studies examining the effect of poor social support on depression among HIV/AIDS patients in Ethiopia have had inconsistent findings. This systematic review and meta-analysis is therefore aimed at estimating the pooled effect of poor social support on depression among HIV/AIDS patients in Ethiopia.
All relevant articles published prior to July 1, 2020, were retrieved from scientific databases: PubMed, Scopus, and Google Scholar systematically. The identified studies reporting the association of depression and poor social support among HIV patients in Ethiopia were included. tests were used to assess the heterogeneity of the studies. Subgroup analysis was done based on tools to determine how pooled estimates of depression vary across tools. The pooled estimate of association between poor social support and depression was reported.
The aggregated meta-analysis revealed a higher odds of depression among patients with poor social support than those who had strong social support (OR: 2.31, 95% CI: 1.69, 2.93). The pooled prevalence of depression among HIV/AIDS patients in Ethiopia was 38.93% (95%: CI: 32.01, 45.84); ( = 94.44%, ≤ 0.001). The subgroup analysis was performed based on tools, and the result showed that the highest pooled prevalence (44.42%) was among primary studies that used the Hospital Anxiety and Depression Scale (HADS) tool.
Human immune deficiency virus and acquired immune deficiency syndrome (HIV/AIDS) patients with poor social support were more likely to develop depression. The pooled prevalence of depression among HIV/AIDS patient was high in Ethiopia. The highest prevalence of depression was observed among studies that used HADS to screen depression. Therefore, we recommend integration of mental health and psychosocial support services into the HIV/AIDS care. Prevention of HIV/AIDS-related stigma for people with HIV/AIDS is also needed to reduce the impact of poor social support.
埃塞俄比亚所属的低收入和中等收入国家,在人类免疫缺陷病毒和获得性免疫缺陷综合征(HIV/AIDS)患者中,抑郁症负担沉重。已确定若干因素与HIV/AIDS患者抑郁症增加有关,包括社会支持不足。然而,关于社会支持不足对埃塞俄比亚HIV/AIDS患者抑郁症影响的研究结果并不一致。因此,本系统评价和荟萃分析旨在估计社会支持不足对埃塞俄比亚HIV/AIDS患者抑郁症的合并效应。
从科学数据库PubMed、Scopus和谷歌学术中系统检索2020年7月1日前发表的所有相关文章。纳入已确定的报告埃塞俄比亚HIV患者抑郁症与社会支持不足之间关联的研究。采用 检验评估研究的异质性。基于工具进行亚组分析,以确定抑郁症合并估计值在不同工具间的差异情况。报告社会支持不足与抑郁症之间关联的合并估计值。
汇总的荟萃分析显示,社会支持不足的患者患抑郁症的几率高于社会支持良好的患者(比值比:2.31,95%置信区间:1.69,2.93)。埃塞俄比亚HIV/AIDS患者抑郁症的合并患病率为38.93%(95%:置信区间:32.01,45.84);( = 94.44%, ≤ 0.001)。基于工具进行亚组分析,结果显示,使用医院焦虑抑郁量表(HADS)工具的初步研究中,合并患病率最高(44.42%)。
社会支持不足的人类免疫缺陷病毒和获得性免疫缺陷综合征(HIV/AIDS)患者更易患抑郁症。埃塞俄比亚HIV/AIDS患者抑郁症合并患病率较高。在使用HADS筛查抑郁症的研究中,抑郁症患病率最高。因此,我们建议将心理健康和社会心理支持服务纳入HIV/AIDS护理。还需要预防与HIV/AIDS相关的耻辱感,以减少社会支持不足的影响。